1. Clark, M., Cobbold, S., Hale, G., and Waldmann, H., 1983, Advantages of rat monoclonal antibodies, Immunol. Today 4:100–101.
2. Ritz, J., Sallan, S. E., Bast, R. C., Lipton, J. M., Clavell, L. A., Feeney, M., Hercend, T., Nathan, D. G., and Schlossman, S. F., 1983, Autologous bone marrow transplantation in cALLa positive acute lymphoblastic leukemia after in vitro treatment with J5 monoclonal antibody and complement, Lancet 2:60–63.
3. Sharp, T. G., Sachs, D. H., Fauci, A. S., Messerschmidt, G. L., and Rosenberg, S. A., 1983, T cell depletion of human bone marrow using monoclonal antibody and complement mediated lysis, Transplantation 35:112–120.
4. Prentice, H. G., Blacklock, H. A., Janossy, G., Gilmore, M. J. M. L., Price-Jones, L., Tidman, N., Trejdosiewicz, L. K., and Skeggs, D. B. L., Panjwani, D., Ball, S., Graphakos, S., Patterson, J., and Hoffbrand, A. V., 1984, Depletion of T lymphocytes in donor marrow prevents significant graft versus host disease in matched allogeneic leukemic marrow transplant recipients, Lancet 1:472–476.
5. Jansen, J., Falkenburg, J. H. F., Stepan, D. E., and LeBien, T. W., 1984, Removal of neoplastic cells from autologous bone marrow grafts with monoclonal antibodies, Sem. Haematol. 21:164–181.